(Q54306535)

27 May 2018

title

Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy. (English)

1 reference

27 May 2018

1 reference

Tao Li

1

1 reference

27 May 2018

Yaping Gui

2

1 reference

27 May 2018

Tao Yuan

3

1 reference

27 May 2018

Guoqiang Liao

4

1 reference

27 May 2018

Cuidong Bian

5

1 reference

27 May 2018

Qiquan Jiang

6

1 reference

27 May 2018

Shengsong Huang

7

1 reference

27 May 2018

Bo Liu

8

1 reference

27 May 2018

Denglong Wu

9

1 reference

27 May 2018

publication date

6 June 2012

1 reference

27 May 2018

published in

BJU International

1 reference

27 May 2018

volume

110

1 reference

27 May 2018

issue

11 Pt C

1 reference

27 May 2018

page(s)

E1125-30

1 reference

27 May 2018

Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Radical prostatectomy versus watchful waiting in early prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Characterization of biochemical recurrence after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Masquerader: high mobility group box-1 and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Analysis of nuclear high mobility group box 1 (HMGB1)-binding proteins in colon cancer cells: clustering with proteins involved in secretion and extranuclear function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

High-mobility group box 1 and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

High-mobility group box 1 (HMGB1) protein: friend and foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Overexpression of high mobility group (HMG) B1 and B2 proteins directly correlates with the progression of squamous cell carcinoma in skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Inflammation and chronic prostatic diseases: evidence for a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Inflammation and prostate cancer: a future target for prevention and therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Natural history of progression after PSA elevation following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

Molecular circuits of solid tumors: prognostic and predictive tools for bedside use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11277.X

10.1111/J.1464-410X.2012.11277.X

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018